SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Pfizer Inc – ‘S-4’ on 9/3/15 – EX-24.1

On:  Thursday, 9/3/15, at 5:09pm ET   ·   Accession #:  1193125-15-311971   ·   File #:  333-206758

Previous ‘S-4’:  ‘S-4/A’ on 6/10/09   ·   Next & Latest:  ‘S-4/A’ on 9/16/15   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/03/15  Pfizer Inc                        S-4                   16:1.7M                                   RR Donnelley/FA

Registration of Securities Issued in a Business-Combination Transaction   —   Form S-4
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-4         Registration of Securities Issued in a              HTML    379K 
                          Business-Combination Transaction                       
 6: EX-4.10     Instrument Defining the Rights of Security Holders  HTML     32K 
 7: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     32K 
 8: EX-4.12     Instrument Defining the Rights of Security Holders  HTML     32K 
 9: EX-4.13     Instrument Defining the Rights of Security Holders  HTML     32K 
 2: EX-4.2      Instrument Defining the Rights of Security Holders  HTML    251K 
 3: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     43K 
 4: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     31K 
 5: EX-4.5      Instrument Defining the Rights of Security Holders  HTML    167K 
10: EX-5.1      Opinion re: Legality                                HTML     15K 
11: EX-12.1     Statement re: Computation of Ratios                 HTML     31K 
12: EX-21.1     Subsidiaries of the Registrant                      HTML    102K 
13: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
14: EX-24.1     Power of Attorney                                   HTML     13K 
15: EX-25.1     Statement re: Eligibility of Trustee                HTML     36K 
16: EX-99.1     Miscellaneous Exhibit                               HTML     78K 


EX-24.1   —   Power of Attorney


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-24.1  

Exhibit 24.1

PFIZER INC.

POWER OF ATTORNEY

The undersigned director of Pfizer Inc., a Delaware corporation, whose signature appears below hereby constitutes and appoints Douglas M. Lankler and Margaret M. Madden and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign registration statements to be filed on Form S-4 or other applicable form, with all exhibits thereto, or any and all amendments (including pre-effective and post-effective amendments) and supplements to a registration statement and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney this 25th day of June, 2015.

 

/s/ Dennis A. Ausiello

   

/s/ W. Don Cornwell

Name:   Dennis A. Ausiello     Name:   W. Don Cornwell
Title:   Director     Title:   Director

/s/ Joseph J. Echevarria

   

/s/ Frances D. Fergusson

Name:   Joseph J. Echevarria     Name:   Frances D. Fergusson
Title:   Director     Title:   Director

/s/ Helen H. Hobbs

   

/s/ James M. Kilts

Name:   Helen H. Hobbs     Name:   James M. Kilts
Title:   Director     Title:   Director

/s/ Shantanu Narayen

   

/s/ Suzanne Nora Johnson

Name:   Shantanu Narayen     Name:   Suzanne Nora Johnson
Title:   Director     Title:   Director

/s/ Ian C. Read

   

/s/ Stephen W. Sanger

Name:   Ian C. Read     Name:   Stephen W. Sanger
Title:   Director     Title:   Director

 

/s/ James C. Smith

Name:   James C. Smith
Title:   Director

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/15/15  SEC                               UPLOAD9/12/17    1:155K Pfizer Inc.
 9/11/15  SEC                               UPLOAD9/12/17    1:199K Pfizer Inc.
Top
Filing Submission 0001193125-15-311971   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 3:17:56.1pm ET